Datos, based in New York and Rabat Gan, Israel, has released a telemedicine tool to enable remote monitoring of patients with COVID-19.

As COVID-19 continues to spread, hospitals are expecting a surge in visitors to clinics and emergency rooms, which would result in a challenging additional burden on an already overstretched medical system. Datos’s solution is specifically designed to support hospitals across the world mitigate such a situation by helping to keep suspected corona patients, and those infected but not requiring hospitalization, at home while still providing them with optimal care.

The Datos COVID-19-specific telemedicine package is already in use at Sheba Medical Center in Israel and has begun implementations in the United States.

“Datos is providing an important solution for the US health care system to monitor COVID-19 remotely, easing the demand for inpatient-based monitoring at hospitals,” says Uri Bettesh, CEO of Datos Health. “The first solution of its kind, we are able to deploy it within 48 hours. It requires no additional resources as it seamlessly integrates with care teams’ existing workflows, providing crucial insights into patients being monitored outside the hospital at a fraction of the cost. Treating patients – who do not require hospitalization – out of emergency rooms could ensure that key resources are available for the most serious cases.”

The Datos COVID-19 solution offers:

For care teams, a fully configured COVID-19 dashboard that includes an overall view of all patients, sorted according to the severity of coronavirus symptoms, the delivery of daily symptom checkout surveys, the seamless launch of virtual visits via video calls (including via text message, without requiring the Datos app), data-driven reminders (to measure temperature and complete surveys), messages and content.

For patients, a user-friendly mobile app (available on iOS and Android) for home hospitalized patients to manually enter their relevant vitals, including body temperature, BP and saturation. Patients will be asked to respond to two types of coronavirus surveys, an initial assessment followed by daily symptom status updates, sent automatically and then scored and correlated with monitored vitals to yield timely reminders, personalized messages and virtual doctor visits via video calls.

For more information, visit Datos.